Genelux (GNLX) closed at $1.92 on November 16, 2026, up 2.9% from the previous close, on volume of 256,749 shares (30-day average 374,934).
Data as of November 16, 2026.
16-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 13, 2026. See the largest for 5, 30, 60 and 90 days
Genelux GAAP EPS of -$0.23 misses by $0.03
Seeking Alpha News (Mon, 16-Nov 5:37 PM ET)
Genelux Corporation Reports Third Quarter Financial Results and Provides Business Updates
Globe Newswire (Mon, 16-Nov 4:14 PM ET)
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.
Genelux trades on the NASDAQ stock market under the symbol GNLX.
As of November 16, 2026, GNLX stock price climbed to $1.92 with 256,749 million shares trading.
GNLX has a beta of 1.07, meaning it tends to be more sensitive to market movements. GNLX has a correlation of 0.03 to the broad based SPY ETF.
GNLX has a market cap of $86.87 million. This is considered a Micro Cap stock.
In the last 3 years, GNLX traded as high as $16.60 and as low as $1.60.
The top ETF exchange traded funds that GNLX belongs to (by Net Assets): VTI, VXF, IWC.
GNLX has underperformed the market in the last year with a price return of -65.2% while the SPY ETF gained +11.2%. GNLX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -27.0% and -7.7%, respectively, while the SPY returned -4.6% and -2.1%, respectively.
GNLX support price is $1.74 and resistance is $1.99 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GNLX shares will trade within this expected range on the day.